Skip to main content
RNAZ logo

RNAZ · Transcode Therapeutics, Inc.

Track RNAZ — free
$2.28 -0.06 (-2.56%) At close · Aug 27
Market Cap
$39.62M
Shares
16.93M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 8
Total Value: $208,057
Total Shares: 33,504

Institutional Ownership Trend

20 quarters

Holder Concentration

Across 8 13F filers · Δ vs Mar 31, 2026
Top Holder
58.6%
Sep 2023 → Jun 2026 · range 28.6% – 92.3%
+17.3 pts
Top 5
97.8%
Sep 2023 → Jun 2026 · range 69.9% – 100.0%
−2.0 pts
Top 10
100.0%
Sep 2023 → Jun 2026 · range 96.6% – 100.0%
0.0 pts
HHI
3,980
Sep 2023 → Jun 2026 · range 1,431 – 8,541
Highly concentrated+1,010

Quarterly Activity

vs Mar 31, 2026
New
2
Increased
1
Decreased
1
Sold Out
2
Unchanged
4
Holder count: 0
Institutional value: -21.7%
Shares held: +8.6%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 8 of 8
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1829635 CUSIP 89357L501 13F (30d) 8 filings 8 filers Visit website Investor relations